Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-002936
Filing Date
2024-01-08
Accepted
2024-01-08 16:15:12
Documents
10
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K/A cgem-20240108.htm   iXBRL 8-K/A 40675
  Complete submission text file 0000950170-24-002936.txt   163295

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgem-20240108.xsd EX-101.SCH 26785
4 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20240108_htm.xml XML 5451
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39856 | Film No.: 24520289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)